Jaguar8 commented on a stock · Dec 4, 2024 02:55

NEWS TODAY

Former Merck USA President Joins Klotho Neurosciences' Board of Directors
Tuesday, 3rd December at 11:00 am
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including ALS, Alzheimer's, and Parkinson's, today announced the appointment of Riad El-Dada, former US President of Merck, to its Board of Directors.

With decades of leadership in the pharmaceutical industry, Mr. El-Dada brings extensive experience in product development, commercialization, and strategic partnerships. During his tenure as US President of Merck, he oversaw commercial teams across a dozen therapeutic areas, managing over $12 billion in revenue. Prior to that role, he served as Managing Director for Merck's Australian and New Zealand operations.
Mr. El-Dada's career is marked by impactful achievements, including negotiating key development and commercialization deals, as well as building collaborations across all phases of the pharmaceutical lifecycle. Before joining Merck, he advised Fortune 500 clients as a consultant with McKinsey & Company. He has also served on the Healthcare Leadership Council in Washington, DC, where he actively engaged with policymakers on Capitol Hill.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

5339 Views

Comment

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

5934Followers

70Following

63KVisitors